chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore left arm; Received the 2nd dose of the Moderna Covid vaccine while pregnant.; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Received the 2nd dose of the Moderna Covid vaccine while pregnant.) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination.     Concomitant products included IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), CALCIUM and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Jul-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Received the 2nd dose of the Moderna Covid vaccine while pregnant.). At the time of the report, EXPOSURE DURING PREGNANCY (Received the 2nd dose of the Moderna Covid vaccine while pregnant.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Pt held breath, slight dusty color to lips noted in 25 sec duration, central pallor noted causes nurse to give vigorous stimulation until patients color returned, I arrived, repeated stimulation which resulted in strong vigorous crying. Event resolved within 1 minutes.
Atenolol - 25mg, pm tab Losartan - 25mg, am tab Tagrisso - 80mg, 1 at night, tab Vitamin B12 - liquid - 5000mg C - 900mg, tab D3 - 5000mg, tab Patient read what she had in front of her - 42 USC 300 Inactivated Influenza, August 15, 2019 (This was not an option in #17
nueropathic pain in both feet within 60 days of  2nd dose.  significant negative reaction after first dose (neuropathic pain over lower half of body, 102.5+ degree fever for 24 hours after onset.  neuropathy in feet after second dose has never gone away.
Patient was given a shot with vaccine that had been left out pass the 12 hour point.  Patient was contacted , no adverse affects or symptoms noted at this time.
Patient has not been able to move arm past shoulder height. Patient had rotator cuff procedure in 1997 but doesn't believe that it is related to the pain since she has gotten the vaccine for at least the past 3 years. The patient will schedule an appointment with specialist to further evaluate the cause of the arm soreness and limited mobility since the vaccination. Patient also reports tingling sensation in her fingers ever since the vaccine.
Notice of red lesion in L arm-pit self treated as fungus (ringworm) - Notice of similar lesion in R arm-pit with no response to antifungals -- Notice of 2021 'Letter to the Editor. 'Pityriasis rosea, COVID-19 and vaccination: New keys to understand an old acquantance' I have had some relief of redness and itching from sporadic UV irradiation and use of topical spray hydrocortisone ~1% OTC - Further study claims this to be an auto-immune reaction with no practical TX - Should be self limiting 6-12 wks - However I'm approx 15 wks and still have some Sx - Suspect 'Patch' on R Deltoid is still presenting -
Patient developed a stomach ache within a few seconds after administration. After a few seconds more he developed vasovagal syncope. He fell on the floor and had seizure like symptoms that last 5 seconds. Regained full consciousness. he was given water and gatorade and was back to normal within 5 to 10 minutes. Ambulance was called.
I went to pharmacy for my Moderna booster shot as I am high risk and my work requires me to be in contact with a lot of people. When the pharmacist gave me the vaccine, I don?t believe she waited to make sure all the liquid was in my arm before she pulled it out because I had vaccine fluid running down my arm, onto my hand. I told her about it and as she was wiping the liquid off of me, she just said, ?You?re probably fine.? I told the pharmacist about it and he ignored my concerns saying, too, that I was ?probably fine.? I have no way of knowing how much of the vaccine was actually given to me as so much of it was dripping down my arm. I called the CDC and they told me to file a report here. I am not comfortable nor do I feel safe going to work now that I know I didn?t get the complete booster due to negligence.
Herpes Zoster: ValACYclovir 1 gram three times a day for 7 days, Vicodin at bedtime as needed for pain, Biofreeze two to three times per day
no adverse event. just covid pediatric vaccine was given by 5/8 inch needle and most of liquid leaked out of syringe and band aid so gave new vaccine with 1 inch needle. called mom 11/13/21 and pt doing great with no adverse reactions
Moderna COVID-19 Vaccine EUA Appetite suppression (episodic anorexia) for last 12 days; abdominal distention, mild weight loss Exact same symptoms as 93 year old father, also Moderna
injection site pain; injection site pain; received the first dose of Shingrix via subcutaneous route; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number Y5J27, expiry date 8th November 2021) for prophylaxis.    On an unknown date, the patient received the 1st dose of Shingrix (subcutaneous). On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional information was provided as follows: The nurse reported that 17 patients received the first dose of Shingrix via subcutaneous route, which led to intramuscular formulation administered by other route. Some of them were female patients. Nurse did not provide initials, date of birth, lot number and expiration dates of the vaccines. She did not said how many patients were male and how many were female. This is 1 of the 17 cases, reported by same reporter.   Follow up information received from the nurse on 3rd April 2020: The patient's demographic details were updated. The patient's past medical history included myocardial infarction (MI in 2010). Concurrent medical conditions included hypertension (since 14th June 2014), dyslipidemia (since 14th June 2017), hypertension (since 14th June 2017) and gastroesophageal reflux disease (since 14th June 2017). On 2nd December 2019, the patient received the 1st dose of Shingrix (subcutaneous) .5 ml. The batch number and expiry date details were updated. On 2nd December 2019, less than a day after receiving Shingrix, the patient experienced injection site pain and injection site itching. On an unknown date, the outcome of the injection site pain and injection site itching were recovered/resolved. The reporter considered the injection site pain and injection site itching to be unrelated to Shingrix. The VAERS details were updated.
She got her shot the 20th had a slight fever that night but the Dr said that it was normal and it was gone the next day. Everything was going good then the night of December 9th I was helping her wipe after potty time and I noticed some little specks. Didnt think much of it since there was none any where else at the time. They got a little bigger and a little more red but i figured shes a kid and was scooting around on the ground so I didnt think much of it put some lotion on. December 13th come and she woke up and had those little spots down on her ankles and im like geeze maybe we have bugs in the house. So I checked everybody and couldnt find anybody else who has any little bumps. We went to my moms which is about 45 mins away spent the day with her and she just keeps getting more spots but only on her legs. Then im like well maybe she has the chicken pox! My mom looks at them and they just started growing right before our eyes!   So I go to head home and in that 45 min window they grew about 4X the original size and are now completely covering her legs and butt. I call my nurse friend and shes like maybe its Hives give her some benadryl and see what they look like in the morning so i do that. In the morning they were a dark deep redish purple almost like a bruise so i called the clinic to get her in. They ask a bunch of questions and have her pee in a hat and come back tell me that its something called HSP.   Dr didn't really explain much on what causes it he just said that it can be caused by a few things. So i check the CDC for it and one of the things listed for a cause is the chicken pox. She hasn't been sick hasn't been around anybody who has been sick we have not changed her diet etc so i fell like its an adverse reaction to the shot.   Once he explained to me some of the symptoms I feel like she was showing sooner then December 9th because shes been complaining about her legs and her hands hurting since the first week of December and he said joint pain is a side effect of HSP.   He prescribed a steroid to help keep it out of the kidney and told us to keep an eye out for bloody urine and bloody stool.   We are currently home and she still has her big purple rash on the bottom half of her body.
Pt vaccinated with Diabetes mellitus was vaccinated with Recombivax HB experienced chest pain and was hospitalized. Treat with unspecified prescription therapy & subsequently recovered
Patient said she doesn't even know if her symptoms are related to the vaccine, but she said she's felt "lousy" for quite some time and specifically stated her left arm is "sore" near the injection site. She also reports right shoulder and wrist pain and left wrist pain. She is not sure if the symptoms started around the time of vaccination, but she thinks they may have... She was advised to follow up with her doctor.
Site where IPV was administered, lt upper arm, was slightly swollen, red and warm to touch.
Patient reported pain in arm starting from shoulder going down all the way to wrist for over a month after taking vaccine.
Delayed fatigue; A spontaneous report was received from a daughter, concerning about her mother (age unknown) who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced delayed fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 05 Jan 2021, after receiving the vaccine, the patient experienced delayed fatigue. Treatment for the event was not provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The outcome for the event, Delayed fatigue is Unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
10AM administered DTP/HIB/OPV 12noon onset crying; 2PM mom contacted who advised to contact MD; 310PM to ER observed pt adverse reaction dx 101 R temp 330pm stopped crying;
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 25-JAN-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB injection, lot # L014426 with expiration date on 08-MAR-2018 (dose and route of administration were not reported). The vaccine underwent a temperature excursion of 47 (46.9) to 77 degrees Fahrenheit for 10 minutes. Digital Data Logger was not involved in recording of the excursion. No previous temperature excursions were reported. No adverse effects were reported. This is one of several reports received from the same source. Sender's Comments: US-009507513-1803USA013072: US-009507513-1803USA013073: US-009507513-1803USA013074.
Employee received her #2 COVID vaccine at 0930.  At 0300 on 1/21/2021 she woke up with temp of 101, chills, bodyaches and pain in the neck and lower back.  Diarrhea starting at 0730.
3 hours of elevated heart rate 118 - 135 bpm from 1am to 4am.   Chills 12:30-1am. Chills 4am- 8 am.   Fever 101.3 from 4am - 8pm.  Headache.  Nausea. Light sensitivity.  Fatigue  Hydration, Tylenol, sleep
pt recvd vax; lt arm became sore 12 hrs p/ vax;pain moved to shoulder & neck; to er for severe pain;given valium & Motrin;
Chills, dizziness, malaise to 103 fever within 2 hours (1:00 PM); fever reduced with Advil in evening to 101; fever reduced by next day (11/05/10) to 99-100; fever reduced by next day (11/06/10) to normal to 99.
Fever; This non-serious spontaneous safety report with reference number 2022SA351274 was received by a partner on 23-AUG-2022 from a health care professional, and forwarded on 24-AUG-2022.  The reporter did not provide an assessment of the causal relationship between Vaxelis and "Fever".   No further information is expected.
Large local reaction (B) legs. Tx cool compresses & Benadryl (L) 8cm x 6cm (R) 6cm x 3.5cm.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L21B) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy. Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP), OMEPRAZOLE, VITAMIN C [ASCORBIC ACID] and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication. On 04-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered greater than 12 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient had no acute and chronic illnesses at the time of vaccination. It was unknown if patient ever had COVID test or diagnosis. It was reported that Booster dose of an outdated Moderna Covid-19 Vaccine was administered to a patient. The vial was first punctured on 01 Apr 2022, and the dose was administered on 04 Apr 2022. The patient was not experiencing any symptoms after receiving the vaccine. No treatment drug was reported.
Injection site reaction - 2 inches diameter red, slightly puffy, very warm circle. It is now extending down the arm to a lesser degree, an additional 3" from circle edge Pt otherwise feels fine, pt has fair skin with freckles.
Eight sessions of diarrhea which led to internal bleeding; fever of 102, and an inability to verbalize thoughts with clarity without tremendous concentration.
pt to ED with c/o cough and worsening SOB; O2 saturation 84% on RA;  found to be positive for COVID; given steroids, ABX, on BiPAP at night, and noninvasive ventilator for several days; pt's condition worsened; DNR; pt passed away in the hospital
Information regarding Prevnar vaccine was received from a healthcare professional regarding a 12-month-old female patient who completed her primary series, having received a fourth dose on 20-Mar-2007. The patient also received a dose of Varivax, a second dose of Hepatitis A Vaccine (manufacturer unknown) and a second dose of M-M-R II (Merck Sharp and Dome) on the same day. On 02-APR-2007, the patient was hospitalized for pneumococcal pneumonia, pneumococcal bacteremia, streptococcal pneumoniae induced hemolytic uremic syndrome, respiratory failure and liver failure. On 20-Mar-2007, the patient received a fourth dose of Prevnar, completing her primary series. On 02-Apr-2007, the patient was hospitalized with a fever (temperature not reported), pneumococcal pneumonia, and thrombocytopenia (laboratory values not available). A blood culture was performed and was positive for Streptococcus pneumoniae. No serotype results were available. The patient was diagnosed with Streptococcal pneumoniae induced hemolytic uremic syndrome which included hemolytic anemia requiring multiple blood transfusions, renal failure requiring peritoneal dialysis, respiratory failure requiring intubation for two weeks and liver failure. The patient was hospitalized for four weeks. It was reported she recovered from all events and was discharged to home on 02-May-2007. Discharge medications included Norvasc, Ativan, aspirin, folate and Poly-Vi-Sol. No additional information was available at the time of this report. Blood culture (results: positive for Streptococcus pneumoniae) was done in Apr-2007.
had a stroke; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (had a stroke) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced CEREBROVASCULAR ACCIDENT (had a stroke) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on 01-Mar-2021 due to CEREBROVASCULAR ACCIDENT. The patient was treated with RIVAROXABAN (XARELTO) at an unspecified dose and frequency; ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency; ATORVASTATIN CALCIUM (LIPITOR) at an unspecified dose and frequency; TAMSULOSIN at an unspecified dose and frequency; METOPROLOL at an unspecified dose and frequency and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for Eye discomfort, at an unspecified dose and frequency. At the time of the report, CEREBROVASCULAR ACCIDENT (had a stroke) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated they were not taking any medications at the time of the first dose. Second dose was administered on 01Sept2021, lot#062E21A. Patient inquires if they should get the booster in a month.  Company comment: This is a spontaneous case concerning a 74-year-old male patient with no medical history reported, who experienced the unexpected serious AESI of Cerebrovascular accident 15 days after the first dose of mRNA-1273 vaccine. The patient's advanced age remains a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-445531 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 74-year-old male patient with no medical history reported, who experienced the unexpected serious AESI of Cerebrovascular accident 15 days after the first dose of mRNA-1273 vaccine. The patient's advanced age remains a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
pt stated that 2 weeks after the shringrix vax that she was experiencing itching and redness under the right breast and around the torso towards the back.   She visiting her PCP and  was prescribed some  oral medication.  These symptoms lasted about 5-6 weeks and was told not to take her second dose by her PCP.
Patient received vaccination on 9/15/11. On 10/6/11 she called to tell us that the muscle still hurt from the injection.
Patient called 06/30/2021 reporting that she has had "marks/small red dots" that would appear then progress to small blisters from head to toe. She claims they started the day following her last COVID19 vaccination and has been "coming and going" since then. Patient states that they are itchy and feels tingly when they first start to appear. I asked if she had spoken with her doctor and she states no. I encouraged/instructed her to seek her physician for follow up  and that I will report what she has going on.
September 30. I woke up at 3AM on the following day that vaccine was administered with slight fever and no energy. When I talk it is almost like whispering. I can hardly get my voice to become louder. I was able to walk but at half step. I have to focus my sight on one direction, otherwise I get dizzy when I move my head.   October 1 - same condition; I started feeling a lot of chill in my body; later on the day, I cough a bit and noticing runny nose. October 2 - My chest becomes tighter. Went to drug store to grab a home kit for Covid. Result is negative. Started taking theraflu for cold. October 3- Still lack of energy with some headache; theraflu seems to provide some relief October 4 and 5 - same condition; feverish
Employee states 2 hrs after receiving flu shot she had severe headache and numbness on (R) side. Symptoms resolved. Incident reported 2 months after event.
On 3/5/2021 patients left elbow showed extreme swelling, while the injection was done on the right arm.  On 3/14 patients 2 knees down to the ankles showed extreme swelling.  By 3/18, patients neck was stiff, and sore created an inability to move and nighttime sleeplessness due to pain/discomfort. By 3/22 patient experienced swelling in the buttocks.  Patient visited ER on 3/16/21, Internist on 3/17/21 and internist again on 3/23/21.  On 3/23/21 internist referred patient to rheumatologist.
ADMINISTRATION ERROR: PATIENT WAS ELIGIBLE FOR BIVALENT COVID VACCINATION BUT WAS ADMINISTERED THE NON-BIVALENT, WE ARE NOTIFYING THE FACILITY THE HCPOA/PATIENT AND PRIMARY DOCTOR.
9/8/21: Patient arrived at the ER due to positive COVID test on 8/24 with lost of taste. Given persistent tachycardia patient will be admitted due to possible post viral myocarditis. Please note: Patient received first dose Moderna vaccine on 3/5/2021 Lot # 011A21A and the second dose on 4/2/2021 Lot # 007B21A